Challenges of infection control capacity in the Middle Eastern countries; time to be actively involved-Reference-Cited by-同舟云学术

Challenges of infection control capacity in the Middle Eastern countries; time to be actively involved

Published:2022-04 Issue:4 Volume:15 Page:448-449
ISSN:1876-0341
Container-title:Journal of Infection and Public Health
language:en
Short-container-title:Journal of Infection and Public Health

Author:

Alshamrani Majid M.,El-Saed Aiman,Farahat Fayssal M.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine

Reference17 articles.

1. Organization of infection control in European hospitals;Hansen;J Hosp Infect,2015

2. The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals;Evans;Philos Trans R Soc Lond B Biol Sci,2021

3. World Health Organization: Minimum requirements for infection prevention and control programmes. URL: 〈file:///C:/Users/ramadana/Downloads/9789241516945-eng.pdf〉 (Last accessed 1 November 2021). 2019.

4. Necessary infrastructure of infection prevention and healthcare epidemiology programs: a review;Bryant;Infect Control Hosp Epidemiol,2016

5. Developing countries have their own characteristic problems with infection control;Raza;J Hosp Infect,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Competency level and determinants among infection prevention and control staff in the Middle East and North Africa region;BMC Public Health;2024-08-15

2. Evaluation of Infection Preventionists' Competencies Using the Association for Professionals in Infection Control and Epidemiology Competency Model in Tertiary Care Government Hospitals, Bahrain;Cureus;2024-07-30

3. Coverage and methods of surveillance of healthcare-associated infections in Middle Eastern and North African countries;American Journal of Infection Control;2023-10

4. Meningococcal disease within the Gulf Cooperation Council Countries;Human Vaccines & Immunotherapeutics;2023-01-02